Hematological Malignancies

References

• Matutes, E. and Polhack, A. (2000) "Morphological and immunophenotypic features of chronic lymphocytic leuke-mia", Rev. Clin. Exp. Hematol. 4, 22–47.
   PubMedGoogle Scholar
• Reed, J.C., Kitada, S., Kim, Y. and Byrd, J. (2002) "Modulating apoptosis pathways in low-grade B-cell malignancies using biological response modifiers", Semin. Oncol. 29, 10–24.
   PubMed Web of Science ®Google Scholar
• Bentley, D.P. and Pepper, C.J. (2000) "The apoptotic pathway: a target for therapy in chronic lymphocytic leukemia", Hematol. Oncol. 18, 87–98.
   PubMed Web of Science ®Google Scholar
• Cheson, B.D., Bennett, J.M., Greyer, M., Kay, N., Keating, M.J., O'Brien, S. and Rai, KR. (1996) "National Cancer Institute-sponsored Working Group guidelines for chronic lympho-cytic leukemia: revised guidelines for diagnosis and treatment", Blood 87, 4990–4997.
   PubMed Web of Science ®Google Scholar
• Amouroux, I., Mossafa, H., Gentilhomme, O., Girot, R., Flandrin, G. and Troussard, X. (1997) "Chronic lymphocytic leukemia with binucleated lymphocytes", Leuk. Lymphoma 27, 533–537.
   PubMed Web of Science ®Google Scholar
• Garcia-Marco, J.A., Price, C.M., Ellis, J., Morey, M., Matutes, E., Lens, D., Colman, S. and Catovsky, D. (1996) "Correlation of trisomy 12 with proliferating cells by combined immunocytochemistry and fluorescence in situ hybridization in chronic lymphocytic leukemia", Leukemia 10, 1705–1711.
   PubMed Web of Science ®Google Scholar
• Oscier, D.G., Matutes, E., Copplestone, A., Pickering, R.M., Chapman, R., Gillingham, R., Catovsky, D. and Hamblin, T.J. (1997) "Atypical lymphocyte morphology: an adverse prognostic factor for disease progression in stage A CLL independent of trisomy 12", Br. J. Haematol. 98, 934–939.
   PubMed Web of Science ®Google Scholar
• Cordone, I., Matutes, E. and Catovsky, D. (1992) "Monoclonal antibody Ki-67 identifies B and T cells in cycle in chronic lymphocytic leukemia: correlation with disease activity", Leukemia 6, 902–906.
   PubMed Web of Science ®Google Scholar
• Ralfkiaer, E., Geisler, C., Hansen, UM. and Hou-Jensen, K. (1983) "Nuclear clefts in chronic lymphocytic leukaemia. A light microscopic and ultrastructural study of a new prognostic parameter", Scand. J. Haematol. 30, 5–12.
   PubMedGoogle Scholar
• Scholzen, T. and Gerdes, J. (2000) "The Ki-67 protein: from the known and unknown", J. Cell. Physiol. 82, 311–322.
   Web of Science ®Google Scholar
• Gerdes, J., Dallenbach, F., Lennert, K., Lemke, H. and Stein, H. (1984) "Growth fractions in malignant non-Hodgkin's lymphomas (NHL) as determined in situ with monoclonal antibody Ki-67", Hematol. Oncol. 2, 365–371.
   PubMedGoogle Scholar
• Falini, B., Canino, S., Sacchi, S., Ciani, C., Martelli, M.F., Gerdes, J., Stein, H., Pileri, S., Gobbi, M., Fagioli, M., Minelli, O. and Flenghi, L. (1988) "Immunocytochemical evaluation of the percentage of proliferating cells in pathological bone marrow and peripheral blood samples with the Ki-67 and anti-bromo-deoxyuridine monoclonal antibodies", Br. J. Haematol. 69, 311–320.
   PubMed Web of Science ®Google Scholar
• Schlette, E., Bueso-Ramos, C., Giles, E, Glassman, A., Hayes, K. and Medeiros, L.J. (2001) "Mature B-cell leukemias with more than 55% prolymphocytes. A heterogeneous group that includes an unusual variant of mantle cell lymphoma", Am. J. Clin. Pathol. 115, 571–581.
   PubMed Web of Science ®Google Scholar
• Sun, X., Medeiros, L.J., Lu, D., Rassidakis, G.Z. and Bueso-Ramos, C. (2003) "Dysplasia and high proliferation rate are common in acute myeloid leukemia with inv(16)(p13q22)", Am. J. Clin. Pathol. 120, 236–245.
   PubMed Web of Science ®Google Scholar
• Estrov, Z., Thall, P.F., Talpaz, M., Estey, E.H., Kantarjian, H.M., Andreeff, M., Harris, D., Van, Q., Walterscheid, M. and Kornblau, S.M. (1998) "Caspase 2 and caspase 3 protein levels as predictors of survival in acute myelogenous leukemia", Blood 92, 3090–3097.
   PubMed Web of Science ®Google Scholar
• Faderl, S., Thall, P.F., Kantarjian, H.M., Talpaz, M., Harris, D., Van, Q., Beran, M., Kornblau, S.M., Pierce, S. and Estrov, Z. (1999) "Caspase 2 and caspase 3 as predictors of complete remission and survival in adults with acute lymphoblastic leukemia", Clin. Cancer Res. 5, 4041–4047.
   PubMed Web of Science ®Google Scholar
• Faderl, S. and Estrov, Z. (2000) "The clinical significance of caspase regulation in acute leukemia", Leuk. Lymphoma 40, 471–481.
   Web of Science ®Google Scholar
• Granziero, L., Ghia, P., Circosta, P., Gottardi, D., Strola, G., Geuna, M., Montagna, L., Piccoli, P., Chilosi, M. and Caligaris-Cappio, E (2001) "Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia", Blood 97, 2777–2783.
   PubMed Web of Science ®Google Scholar
• Jurlander, J. (1998) "The cellular biology of B-cell chronic lymphocytic leukemia", Crit. Rev. Oncol. Hematol. 27, 29–52.
   PubMed Web of Science ®Google Scholar
• Meinhardt, G., Wendtner, CM. and Hallek, M. (1999) "Molecular pathogenesis of chronic lymphocytic leukemia: factors and signaling pathways regulating cell growth and survival", J. Mol. Med. 77, 282–293.
   PubMed Web of Science ®Google Scholar
• Delmer, A., Ajchenbaum-Cymbalista, F., Tang, R., Ramond, S., Faussat, AM., Marie, J.P. and Zittoun, R. (1995) "Over-expression of cyclin D2 in chronic B-cell malignancies", Blood 85, 2870–2876.
   PubMed Web of Science ®Google Scholar
• Levy, V, Ugo, V, Delmer, A., Tang, R., Ramond, S., Perrot, J.Y., Vrhovac, R., Marie, J.P., Zittoun, R. and Ajchenbaum-Cymbalista, E (1999) "Cyclin D1 overexpression allows identification of an aggressive subset of leukemic lympho-proliferative disorder", Leukemia 13, 1343–1351.
   PubMed Web of Science ®Google Scholar
• Wolowiec, D., Ciszak, L., Kosmaczewska, A., Bocko, D., Teodorowska, R., Frydecka, I. and Kuliczkowski, K. (2001) "Cell cycle regulatory proteins and apoptosis in B-cell chronic lymphocytic leukemia", Haematologica 86, 1296–1304.
   PubMed Web of Science ®Google Scholar
• Decker, T., Schneller, E, Hipp, S., Miething, C., Jahn, T., Duyster, J. and Peschel, C. (2002) "Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cydin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27", Leukemia 16, 327–334.
   PubMed Web of Science ®Google Scholar
• Dono, M., Hashimoto, S., Fais, F., Trejo, V, Allen, S.L., Lichtman, S.M., Schulman, P., Vinciguerra, V.P., Sellars, B., Gregersen, P.K., Ferrarini, M. and Chiorazzi, N. (1996) "Evidence for progenitors of chronic lymphocytic leukemia B cells that undergo intraclonal differentiation and diversi-fication", Blood 87, 1586–1594.
   PubMed Web of Science ®Google Scholar
• Estrov, Z., Zipf, T.F., O'Brien, S., Harris, D., Ouspenskaia, UV, Van, Q., Robertson, L.E., Kantarjian, H.M., Deisseroth, A.B., Talpaz, M. and Keating, M. (1994) "Identification of chronic lymphocytic leukemia (CLL) progenitor cells", Blood 84, 458.
   Web of Science ®Google Scholar
• Sanchez, ML., Almeida, J., Gonzalez, D., Gonzalez, M., Garcia-Marcos, MA., Balanzategui, A., Lopez-Berges, MC., Nomdedeu, J., Vallespi, T., Barb on, M., Martin, A., de la Fuente, P., Martin-Nunez, G., Fernandez-Calvo, J., Hernandez, J.M., San Miguel, J.F. and Orfao, A. (2003) "Incidence and dinicobiologic characteristics of leukemic B-cell chronic lymphoproliferative disorders with more than one B-cell clone", Blood 102, 2994–3002.
   PubMed Web of Science ®Google Scholar
• Oliveira, GB., Pereira, F.G., Metze, K. and Lorand-Metze, I. (2001) "Spontaneous apoptosis in chronic lymphocytic leukemia and its relationship to clinical and cell kinetic parameters", Cytometry 46, 329–335.
   PubMedGoogle Scholar
• Krajewski, S., Gascoyne, RD., Zapata, J.M., Krajewska, M., Kitada, S., Chhanabhai, M., Horsman, D., Berean, K., Piro, L.D., Fugier-Vivier, I., Liu, Y.J., Wang, H.G. and Reed, J.C. (1997) "Immunolocalization of the ICE /Ced-3-family pro-tease, CPP32 (caspase-3), in non-Hodgkin's lymphomas, chronic lymphocytic leukemias, and reactive lymph nodes", Blood 89, 3817–3825.
   PubMed Web of Science ®Google Scholar
• Choi, J.W. (2002) "Apoptotic rate varies with detection methods in myelodysplastic syndromes: impact of method selection", Fur. J. Haematol. 69, 62–63.
   PubMed Web of Science ®Google Scholar
• Dewald, G.W., Brockman, S.R., Paternoster, S.F., Bone, ND., O'Fallon, J.R., Allmer, C., James, C.D., Jelinek, D.F., Tschumper, R.C., Hanson, C.A., Pruthi, R.K., Witzig, T.E., Call, T.G. and Kay, N.E. (2003) "Chromosome abnormalities detected by interphase fluorescence in situ hybridization: correlation with significant biological features of B-cell chronic lymphocytic leukaemia", Br. J. Haematol. 121, 287–295.
   PubMed Web of Science ®Google Scholar
• Byrd, J.C., Smith, L., Hackbarth, M.L., Flinn, IA., Young, D., Proffitt, J.H. and Heerema, N.A. (2003) "Inter-phase cytogenetic abnormalities in chronic lymphocytic leukemia may predict response to rituximab", Cancer Res. 63, 36–38.
   PubMed Web of Science ®Google Scholar
• Shanafelt, T.D., Geyer, S.M. and Kay, N.E. (2004) "Prognosis at diagnosis: integrating molecular biologic insights into clinical practice for patients with CLL", Blood 103, 1202–1210.
   PubMed Web of Science ®Google Scholar
• Damle, R.N., Wasil, T., Fais, F., Ghiotto, F., Valetto, A., Allen, S.L., Buchbinder, A., Budman, D., Dittmar, K., Kolitz, J., Lichtman, S.M., Schulman, P., Vinciguerra, V.P., Rai, K.R., Ferrarini, M. and Chiorazzi, N. (1999) "Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia", Blood 94, 1840–1847.
   PubMed Web of Science ®Google Scholar
• Hamblin, T.J., Davis, Z., Gardiner, A., Oscier, D.G. and Stevenson, F.K. (1999) "Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lympho-cytic leukemia", Blood 94, 1848–1854.
   PubMed Web of Science ®Google Scholar
• Chen, L., Widhopf, G., Huynh, L., Rassenti, L., Rai, KR., Weiss, A. and Kipps, T.J. (2002) "Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia", Blood 100, 4609–4614.
   PubMed Web of Science ®Google Scholar
• Rosenwald, A., Alizadeh, A.A., Widhopf, G., Simon, R., Davis, R.E., Yu, X., Yang, L., Pickeral, O.K., Rassenti, L.Z., Powell, J., Botstein, D., Byrd, J.C., Greyer, M.R., Cheson, B.D., Chiorazzi, N., Wilson, W.H., Kipps, T.J., Brown, P.O. and Staudt, L.M. (2001) "Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia", J. Exp. Med. 194, 1639–1647.
   PubMed Web of Science ®Google Scholar
• Bogner, C., Schneller, F., Hipp, S., Ringshausen, I., Peschel, C. and Decker, T. (2003) "Cycling B-CLL cells are highly susceptible to inhibition of the proteasome: involve-ment of p27, early D-type cyclins, Box, and caspase-dependent and -independent pathways", Exp. Hematol. 31, 218–225.
   PubMed Web of Science ®Google Scholar
• Decker, T., Hipp, S., Ringhausen, I., Bogner, C., Oelsner, M., Schneller, F. and Peschel, C. (2003) "Rapamycin-induced Cl arrest in cyclin B-CLL cells is associated with reduced expression of cyclin D3, cyclin E, cydin A, and survivin", Blood 101, 278–285.
   PubMed Web of Science ®Google Scholar